Surgical treatment pattern and outcomes in epithelial ovarian cancer patients from a cancer institute in Kerala, India

Surgical treatment pattern and outcomes in epithelial ovarian cancer patients from a cancer institute in Kerala, India

To evaluate the treatment and survival pattern of patients with advanced epithelial ovarian cancer. Retrospective study of all advanced epithelial ovarian cancer patients treated in the department of gynaecologic oncology from an academic centre, in a four year period from 1 January 2008-31 December...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ecancermedicalscience 2016-02, Vol.10, p.619-619
Hauptverfasser: Georgeena, P, Rajanbabu, Anupama, Vijaykumar, D K, Pavithran, K, Sundaram, K R, Deepak, K S, Sanal, M R
Format: Artikel
Sprache:eng
Schlagworte:
Ovarian cancer
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 619
container_issue
container_start_page 619
container_title Ecancermedicalscience
container_volume 10
creator Georgeena, P
Rajanbabu, Anupama
Vijaykumar, D K
Pavithran, K
Sundaram, K R
Deepak, K S
Sanal, M R
description To evaluate the treatment and survival pattern of patients with advanced epithelial ovarian cancer. Retrospective study of all advanced epithelial ovarian cancer patients treated in the department of gynaecologic oncology from an academic centre, in a four year period from 1 January 2008-31 December 2011. All patients with advanced epithelial ovarian cancer (stage III and IV) who underwent surgery from 2008-2011and had a follow-up of at least three months after completion of treatment were included. The decision on whether primary surgery or neoadjuvant chemotherapy (NACT) in advanced ovarian cancer was based on age, performance status, clinical and imaging findings. A total of 178 cases of epithelial ovarian cancer were operated on during this four year period. Among them 28 patients were recurrent cases, 22 had early stages of ovarian cancer, and the rest 128 had stage III and IV ovarian cancer. In these 128 patients, 50(39.1%) underwent primary surgery and 78(60.9%) had NACT followed by surgery. In the primary surgery group 36(72.0%) patients had optimal debulking while in the NACT group 59(75.6%) patient had optimal debulking. With a median follow-up of 34 months, the median overall survival (OS) and progression free survival (PFS) was 53 and 49 months respectively. Patients who underwent primary surgery had better median PFS than patients who had NACT (56 months versus 39 months, p = 0.002). In stage III C the difference median PFS was significant for those treated with primary surgery when compared with NACT (55 months versus 39 months, p = 0.012). In patients who had optimal debulking to no residual disease (n = 90), primary surgery gave a significant improved PFS (59 months versus 38 months, p = 0.001) when compared with NACT. In univariate analysis, NACT was associated with increased risk of death (HR: 0.350; CI: 0.177-0.693). In advanced epithelial ovarian cancer, primary surgery seems to have a definite survival advantage over NACT in patients who can be optimally debulked to no residual disease.
doi_str_mv 10.3332/ecancer.2016.619
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4754116</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1953263338</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-bf5d2714a57c6669249caffaa01583660f4f3bd1a529be27f223360c826840693</originalsourceid><addsrcrecordid>eNpdkc1rHCEYxiW05LP3norQSw_ZrR-jM3MphNAmoYEemp7lXec1MczoVp2F_vdx2U1IelL0eV6fxx8hHzlbSinFV7QQLKalYFwvNe8PyDFvVbPQmql3r_ZH5CTnR8aqRKhDciR0zyVr2THZ_J7Tvbcw0pIQyoSh0DWUgilQCAONc7Fxwkx9oLj25QFHX8VxA8lDoLv3tw5fnZm6FCcKz8c-5OLLXHDr_okJRjinN2HwcEbeOxgzftivp-TPj-93l9eL219XN5cXtwvbiKYsVk4NouUNqNZqrXvR9BacA2BcdbI2c42Tq4GDEv0KReuEkFIz2wndNUz38pR8281dz6sJB1tD1hRmnfwE6Z-J4M3bm-AfzH3cmKZ-Hee6DviyH5Di3xlzMZPPFscRAsY5G97qTqleKVmln_-TPsY5hVrP8F5JoSuyrqrYTmVTzDmhewnDmdlCNXuoZgvVVGLV8ul1iRfDM0X5BDCFoII</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1953263338</pqid></control><display><type>article</type><title>Surgical treatment pattern and outcomes in epithelial ovarian cancer patients from a cancer institute in Kerala, India</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Georgeena, P ; Rajanbabu, Anupama ; Vijaykumar, D K ; Pavithran, K ; Sundaram, K R ; Deepak, K S ; Sanal, M R</creator><creatorcontrib>Georgeena, P ; Rajanbabu, Anupama ; Vijaykumar, D K ; Pavithran, K ; Sundaram, K R ; Deepak, K S ; Sanal, M R</creatorcontrib><description>To evaluate the treatment and survival pattern of patients with advanced epithelial ovarian cancer. Retrospective study of all advanced epithelial ovarian cancer patients treated in the department of gynaecologic oncology from an academic centre, in a four year period from 1 January 2008-31 December 2011. All patients with advanced epithelial ovarian cancer (stage III and IV) who underwent surgery from 2008-2011and had a follow-up of at least three months after completion of treatment were included. The decision on whether primary surgery or neoadjuvant chemotherapy (NACT) in advanced ovarian cancer was based on age, performance status, clinical and imaging findings. A total of 178 cases of epithelial ovarian cancer were operated on during this four year period. Among them 28 patients were recurrent cases, 22 had early stages of ovarian cancer, and the rest 128 had stage III and IV ovarian cancer. In these 128 patients, 50(39.1%) underwent primary surgery and 78(60.9%) had NACT followed by surgery. In the primary surgery group 36(72.0%) patients had optimal debulking while in the NACT group 59(75.6%) patient had optimal debulking. With a median follow-up of 34 months, the median overall survival (OS) and progression free survival (PFS) was 53 and 49 months respectively. Patients who underwent primary surgery had better median PFS than patients who had NACT (56 months versus 39 months, p = 0.002). In stage III C the difference median PFS was significant for those treated with primary surgery when compared with NACT (55 months versus 39 months, p = 0.012). In patients who had optimal debulking to no residual disease (n = 90), primary surgery gave a significant improved PFS (59 months versus 38 months, p = 0.001) when compared with NACT. In univariate analysis, NACT was associated with increased risk of death (HR: 0.350; CI: 0.177-0.693). In advanced epithelial ovarian cancer, primary surgery seems to have a definite survival advantage over NACT in patients who can be optimally debulked to no residual disease.</description><identifier>ISSN: 1754-6605</identifier><identifier>EISSN: 1754-6605</identifier><identifier>DOI: 10.3332/ecancer.2016.619</identifier><identifier>PMID: 26913070</identifier><language>eng</language><publisher>England: Cancer Intelligence</publisher><subject>Ovarian cancer</subject><ispartof>Ecancermedicalscience, 2016-02, Vol.10, p.619-619</ispartof><rights>the authors; licensee ecancermedicalscience. 2016. This work is licensed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>the authors; licensee ecancermedicalscience. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-bf5d2714a57c6669249caffaa01583660f4f3bd1a529be27f223360c826840693</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754116/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754116/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26913070$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Georgeena, P</creatorcontrib><creatorcontrib>Rajanbabu, Anupama</creatorcontrib><creatorcontrib>Vijaykumar, D K</creatorcontrib><creatorcontrib>Pavithran, K</creatorcontrib><creatorcontrib>Sundaram, K R</creatorcontrib><creatorcontrib>Deepak, K S</creatorcontrib><creatorcontrib>Sanal, M R</creatorcontrib><title>Surgical treatment pattern and outcomes in epithelial ovarian cancer patients from a cancer institute in Kerala, India</title><title>Ecancermedicalscience</title><addtitle>Ecancermedicalscience</addtitle><description>To evaluate the treatment and survival pattern of patients with advanced epithelial ovarian cancer. Retrospective study of all advanced epithelial ovarian cancer patients treated in the department of gynaecologic oncology from an academic centre, in a four year period from 1 January 2008-31 December 2011. All patients with advanced epithelial ovarian cancer (stage III and IV) who underwent surgery from 2008-2011and had a follow-up of at least three months after completion of treatment were included. The decision on whether primary surgery or neoadjuvant chemotherapy (NACT) in advanced ovarian cancer was based on age, performance status, clinical and imaging findings. A total of 178 cases of epithelial ovarian cancer were operated on during this four year period. Among them 28 patients were recurrent cases, 22 had early stages of ovarian cancer, and the rest 128 had stage III and IV ovarian cancer. In these 128 patients, 50(39.1%) underwent primary surgery and 78(60.9%) had NACT followed by surgery. In the primary surgery group 36(72.0%) patients had optimal debulking while in the NACT group 59(75.6%) patient had optimal debulking. With a median follow-up of 34 months, the median overall survival (OS) and progression free survival (PFS) was 53 and 49 months respectively. Patients who underwent primary surgery had better median PFS than patients who had NACT (56 months versus 39 months, p = 0.002). In stage III C the difference median PFS was significant for those treated with primary surgery when compared with NACT (55 months versus 39 months, p = 0.012). In patients who had optimal debulking to no residual disease (n = 90), primary surgery gave a significant improved PFS (59 months versus 38 months, p = 0.001) when compared with NACT. In univariate analysis, NACT was associated with increased risk of death (HR: 0.350; CI: 0.177-0.693). In advanced epithelial ovarian cancer, primary surgery seems to have a definite survival advantage over NACT in patients who can be optimally debulked to no residual disease.</description><subject>Ovarian cancer</subject><issn>1754-6605</issn><issn>1754-6605</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkc1rHCEYxiW05LP3norQSw_ZrR-jM3MphNAmoYEemp7lXec1MczoVp2F_vdx2U1IelL0eV6fxx8hHzlbSinFV7QQLKalYFwvNe8PyDFvVbPQmql3r_ZH5CTnR8aqRKhDciR0zyVr2THZ_J7Tvbcw0pIQyoSh0DWUgilQCAONc7Fxwkx9oLj25QFHX8VxA8lDoLv3tw5fnZm6FCcKz8c-5OLLXHDr_okJRjinN2HwcEbeOxgzftivp-TPj-93l9eL219XN5cXtwvbiKYsVk4NouUNqNZqrXvR9BacA2BcdbI2c42Tq4GDEv0KReuEkFIz2wndNUz38pR8281dz6sJB1tD1hRmnfwE6Z-J4M3bm-AfzH3cmKZ-Hee6DviyH5Di3xlzMZPPFscRAsY5G97qTqleKVmln_-TPsY5hVrP8F5JoSuyrqrYTmVTzDmhewnDmdlCNXuoZgvVVGLV8ul1iRfDM0X5BDCFoII</recordid><startdate>20160204</startdate><enddate>20160204</enddate><creator>Georgeena, P</creator><creator>Rajanbabu, Anupama</creator><creator>Vijaykumar, D K</creator><creator>Pavithran, K</creator><creator>Sundaram, K R</creator><creator>Deepak, K S</creator><creator>Sanal, M R</creator><general>Cancer Intelligence</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160204</creationdate><title>Surgical treatment pattern and outcomes in epithelial ovarian cancer patients from a cancer institute in Kerala, India</title><author>Georgeena, P ; Rajanbabu, Anupama ; Vijaykumar, D K ; Pavithran, K ; Sundaram, K R ; Deepak, K S ; Sanal, M R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-bf5d2714a57c6669249caffaa01583660f4f3bd1a529be27f223360c826840693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Ovarian cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Georgeena, P</creatorcontrib><creatorcontrib>Rajanbabu, Anupama</creatorcontrib><creatorcontrib>Vijaykumar, D K</creatorcontrib><creatorcontrib>Pavithran, K</creatorcontrib><creatorcontrib>Sundaram, K R</creatorcontrib><creatorcontrib>Deepak, K S</creatorcontrib><creatorcontrib>Sanal, M R</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Ecancermedicalscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Georgeena, P</au><au>Rajanbabu, Anupama</au><au>Vijaykumar, D K</au><au>Pavithran, K</au><au>Sundaram, K R</au><au>Deepak, K S</au><au>Sanal, M R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surgical treatment pattern and outcomes in epithelial ovarian cancer patients from a cancer institute in Kerala, India</atitle><jtitle>Ecancermedicalscience</jtitle><addtitle>Ecancermedicalscience</addtitle><date>2016-02-04</date><risdate>2016</risdate><volume>10</volume><spage>619</spage><epage>619</epage><pages>619-619</pages><issn>1754-6605</issn><eissn>1754-6605</eissn><abstract>To evaluate the treatment and survival pattern of patients with advanced epithelial ovarian cancer. Retrospective study of all advanced epithelial ovarian cancer patients treated in the department of gynaecologic oncology from an academic centre, in a four year period from 1 January 2008-31 December 2011. All patients with advanced epithelial ovarian cancer (stage III and IV) who underwent surgery from 2008-2011and had a follow-up of at least three months after completion of treatment were included. The decision on whether primary surgery or neoadjuvant chemotherapy (NACT) in advanced ovarian cancer was based on age, performance status, clinical and imaging findings. A total of 178 cases of epithelial ovarian cancer were operated on during this four year period. Among them 28 patients were recurrent cases, 22 had early stages of ovarian cancer, and the rest 128 had stage III and IV ovarian cancer. In these 128 patients, 50(39.1%) underwent primary surgery and 78(60.9%) had NACT followed by surgery. In the primary surgery group 36(72.0%) patients had optimal debulking while in the NACT group 59(75.6%) patient had optimal debulking. With a median follow-up of 34 months, the median overall survival (OS) and progression free survival (PFS) was 53 and 49 months respectively. Patients who underwent primary surgery had better median PFS than patients who had NACT (56 months versus 39 months, p = 0.002). In stage III C the difference median PFS was significant for those treated with primary surgery when compared with NACT (55 months versus 39 months, p = 0.012). In patients who had optimal debulking to no residual disease (n = 90), primary surgery gave a significant improved PFS (59 months versus 38 months, p = 0.001) when compared with NACT. In univariate analysis, NACT was associated with increased risk of death (HR: 0.350; CI: 0.177-0.693). In advanced epithelial ovarian cancer, primary surgery seems to have a definite survival advantage over NACT in patients who can be optimally debulked to no residual disease.</abstract><cop>England</cop><pub>Cancer Intelligence</pub><pmid>26913070</pmid><doi>10.3332/ecancer.2016.619</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1754-6605
ispartof Ecancermedicalscience, 2016-02, Vol.10, p.619-619
issn 1754-6605
1754-6605
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4754116
source DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Ovarian cancer
title Surgical treatment pattern and outcomes in epithelial ovarian cancer patients from a cancer institute in Kerala, India
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T10%3A52%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surgical%20treatment%20pattern%20and%20outcomes%20in%20epithelial%20ovarian%20cancer%20patients%20from%20a%20cancer%20institute%20in%20Kerala,%20India&rft.jtitle=Ecancermedicalscience&rft.au=Georgeena,%20P&rft.date=2016-02-04&rft.volume=10&rft.spage=619&rft.epage=619&rft.pages=619-619&rft.issn=1754-6605&rft.eissn=1754-6605&rft_id=info:doi/10.3332/ecancer.2016.619&rft_dat=%3Cproquest_pubme%3E1953263338%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1953263338&rft_id=info:pmid/26913070&rfr_iscdi=true